You are here

Eli Lilly

Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study

BioSpace

Wed, 04/17/24 - 11:32 am

Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says

Reuters

Wed, 04/17/24 - 11:21 am

Lilly's Prevail walks away from gene editing collab with Precision

Fierce Biotech

Wed, 04/17/24 - 11:11 am

Prevail Therapeutics

Precision Biosciences

Eli Lilly's nationwide insulin pricing settlement called off

Reuters

Mon, 04/15/24 - 09:28 pm

4 Investigational Weight Loss Drugs That Could Change the Market

BioSpace

Mon, 04/15/24 - 11:09 am

Viking Therapeutics

Inversago Pharma

Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy

BioSpace

Fri, 04/12/24 - 11:13 am

compounding pharmacies

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

Pharmaphorum

Thu, 04/11/24 - 10:52 am

Alzheimer's disease

breakthrough designation

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk

BioSpace

Tue, 04/9/24 - 11:11 am

Jardiance doesn’t cut it in post-heart attack trial

Pharmaphorum

Mon, 04/8/24 - 11:21 am

Boehringer Ingelheim

clinical trials

Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says

Fierce Pharma

Tue, 04/2/24 - 10:03 pm

Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds

Stat

Thu, 03/28/24 - 11:19 am

aspiration pneumonia

In banner year, Lilly rewards CEO David Ricks with 24% boost in total pay to $26.6M

Fierce Pharma

Mon, 03/25/24 - 10:36 pm

executive compensation

Could Viking Therapeutics Become the Next Eli Lilly?

Motley Fool

Fri, 03/22/24 - 09:27 am

Viking Therapeutics

Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s?

Biopharma Reporter

Mon, 03/18/24 - 11:02 am

Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time

Reuters

Sun, 03/17/24 - 09:17 pm

Lilly makes weight-loss drug Zepbound available through Amazon pharmacy

BioSpace

Wed, 03/13/24 - 11:18 am

Amazon pharmacy

FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit

Fierce Biotech

Tue, 03/12/24 - 11:34 am

Alzheimer's disease

To boldly go back: Lilly charts 2nd space trip in 4 months, this time with chronic disease tests

Fierce Biotech

Tue, 03/12/24 - 11:17 am

chronic disease

Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color

Fierce Biotech

Mon, 03/11/24 - 05:11 pm

Setbacks reset views on highly touted Alzheimer's and ALS drugs

Axios

Mon, 03/11/24 - 05:06 pm

Alzheimer's disease

Pages